PIK3CA Gene Complete Identifier and Functional Mapping Reference

Provide a comprehensive cross-database identifier and functional mapping reference for human PIK3CA. This should serve as a definitive lookup resource …

Provide a comprehensive cross-database identifier and functional mapping reference for human PIK3CA. This should serve as a definitive lookup resource for researchers. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 1: GENE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Provide ALL gene-level database identifiers: - HGNC ID and approved symbol - Ensembl gene ID (ENSG) - NCBI Entrez Gene ID - OMIM gene/locus ID - Genomic location: chromosome, start position, end position, strand ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 2: TRANSCRIPT IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL transcript-level identifiers: - Ensembl transcripts: ALL ENST IDs with biotype (protein_coding, etc.) How many total transcripts? - RefSeq transcripts: ALL NM_ mRNA accessions Mark which is MANE Select (canonical clinical standard) - CCDS IDs: ALL consensus coding sequence identifiers For the CANONICAL/MANE SELECT transcript: - List ALL exon IDs (ENSE) with genomic coordinates - Total exon count ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 3: PROTEIN IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL protein-level identifiers: - UniProt accessions: ALL entries (reviewed and unreviewed) Mark the canonical reviewed entry - RefSeq protein: ALL NP_ accessions Protein domains and families: - List ALL annotated domains/families with identifiers - Include: domain name, type (domain/family/superfamily), and ID ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 4: STRUCTURE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Experimental structures: - List ALL PDB structure IDs - For each: experimental method (X-ray, NMR, Cryo-EM) and resolution - Total PDB structure count Predicted structures: - AlphaFold model ID and confidence metrics (pLDDT) ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 5: CROSS-SPECIES ORTHOLOGS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List orthologous genes in key model organisms (where available): - Mouse (Mus musculus): gene ID, symbol - Rat (Rattus norvegicus): gene ID, symbol - Zebrafish (Danio rerio): gene ID, symbol - Fruit fly (Drosophila melanogaster): gene ID, symbol - Worm (C. elegans): gene ID, symbol - Yeast (S. cerevisiae): gene ID, symbol ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 6: CLINICAL VARIANTS & AI PREDICTIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Clinical variant annotations: - Total variant count in clinical databases - Breakdown by classification: Pathogenic, Likely Pathogenic, Uncertain Significance (VUS), Likely Benign, Benign - List TOP 50 pathogenic/likely pathogenic variants with: variant ID, HGVS notation, associated condition AI-based variant effect predictions: - Splice effect predictions: Total count List TOP 50 predicted splice-altering variants with delta scores - Missense pathogenicity predictions: Total count List TOP 50 predicted pathogenic missense variants with scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 7: BIOLOGICAL PATHWAYS & GENE ONTOLOGY ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Pathway membership: - List ALL biological pathways this gene participates in - Include pathway IDs and names - Total pathway count Gene Ontology annotations: - Biological Process: count and TOP 20 terms with IDs - Molecular Function: count and TOP 20 terms with IDs - Cellular Component: count and TOP 20 terms with IDs ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 8: PROTEIN INTERACTIONS & MOLECULAR NETWORKS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Protein-protein interactions: - Total interaction count - List TOP 50 highest-confidence interacting proteins with scores Protein similarity (evolutionary and structural): - Structural/embedding similarity: How many similar proteins? List TOP 20 with similarity scores - Sequence homology: How many homologous proteins? List TOP 20 with identity/similarity scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 9: TRANSCRIPTION FACTOR REGULATORY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene encodes a transcription factor: Downstream targets (genes regulated BY this TF): - Total target gene count - List TOP 50 target genes with regulation type (activates/represses) DNA binding profiles: - List ALL known binding motif IDs - Motif family classification Upstream regulators (TFs that regulate THIS gene): - List known transcriptional regulators with evidence type ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 10: DRUG & PHARMACOLOGY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene/protein is a drug target: Targeting molecules: - How many drug/compound molecules target this protein? - List TOP 30 molecules by development phase - Include: molecule ID, name, mechanism, highest development phase Clinical trials: - How many clinical trials involve drugs targeting this gene? - List TOP 20 trials with: trial ID, phase, status, intervention Pharmacogenomics: - Known drug-gene interactions affecting drug response - Dosing guidelines if any exist ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 11: EXPRESSION PROFILES ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Tissue expression: - Which tissues express this gene most highly? - List TOP 30 tissues with expression scores/levels - Note any tissue-specific or tissue-enriched patterns Cell type expression: - Which cell types show highest expression? - List TOP 30 cell types with expression scores - Note any cell type-specific patterns Single-cell expression data (if available): - Which single-cell datasets/experiments include this gene? - Notable cell population patterns ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 12: DISEASE ASSOCIATIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Mendelian/monogenic disease links: - What diseases are caused by mutations in this gene? - List ALL associated diseases with: disease name, disease ID, inheritance pattern, evidence level Phenotype associations: - What clinical phenotypes are associated with this gene? - List TOP 50 phenotype terms with IDs Complex trait associations (GWAS): - What traits/diseases are linked via genome-wide association studies? - List TOP 30 GWAS associations with: trait, study ID, p-value, effect size if available ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ FORMATTING REQUIREMENTS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ - Present each section with clear headers - Use tables for listing multiple items - Always include COUNTS for every category - For lists with >50 items: show total count + TOP 50 - For lists with <50 items: show ALL items - Always include database identifiers (IDs), not just names - Mark canonical/primary/reviewed entries where applicable - If a section has no data available, state "No data available" rather than omitting the section

Structured Data Sources

This answer was generated using Claude Opus 4.5 + BioBTree MCP, querying 35 biological databases.

Further analyze this answer or run your own queries with BioBTree MCP.

Datasets: alphafold, alphamissense, bgee, bgee_evidence, bindingdb, biogrid_interaction, ccds, chembl_molecule, chembl_target, clinvar, collectri, diamond_similarity, ensembl, entrez, esm2_similarity, exon, gencc, go, gwas, hgnc, hpo, intact, interpro, mim, orphanet, ortholog, paralog, pdb, pharmgkb_gene, reactome, refseq, spliceai, string_interaction, transcript, uniprot
Generated: 2026-03-26 — For the latest data, query BioBTree directly via MCP or API.
View API calls (48)
PIK3CA

PIK3CA Complete Identifier and Functional Mapping Reference


Section 1: Gene Identifiers

DatabaseIdentifierValue
HGNC IDHGNC:8975Approved
HGNC SymbolPIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
Ensembl GeneENSG00000121879Human
NCBI Entrez5290protein-coding
OMIM171834Gene/Locus
Gene GroupPhosphatidylinositol 3-kinase family
AliasesPI3K, PI3K-alpha, p110-alpha, CCM4, CLAPO, CLOVE, CWS5, MCAP, MCM
Genomic Location
FeatureValue
Chromosome3
Cytogenetic Band3q26.32
Start Position179,148,114
End Position179,240,093
Strand+ (forward)
Genomic AccessionNC_000003.12
Gene Length91,979 bp

Section 2: Transcript Identifiers Ensembl Transcripts (Total: 15)

Transcript IDBiotypeStartEndUTR5 StartUTR3 End
ENST00000263967protein_coding179,148,357179,240,093179,198,750179,240,093
ENST00000462255retained_intron179,218,209179,235,016--
ENST00000468036protein_coding179,149,527179,199,179179,198,750-
ENST00000477735protein_coding179,148,114179,198,888179,198,750-
ENST00000643187protein_coding179,148,574179,235,098179,198,750179,235,098
ENST00000674534retained_intron179,202,977179,235,084--
ENST00000674622nonsense_mediated_decay179,210,524179,235,084-179,235,084
ENST00000675467retained_intron179,196,019179,235,371--
ENST00000675786nonsense_mediated_decay179,149,001179,235,084179,198,750179,235,084
ENST00000675796retained_intron179,226,882179,235,107--
ENST00000876545protein_coding179,148,589179,235,137179,198,750179,235,137
ENST00000913499protein_coding179,148,177179,237,493179,198,750179,237,493
ENST00000913500protein_coding179,148,428179,235,325179,198,750179,235,325
ENST00000955189protein_coding179,148,186179,235,121179,198,750179,235,121
ENST00000955190protein_coding179,148,256179,235,120179,198,750179,235,120
Summary: 9 protein-coding, 4 retained introns, 2 NMD transcripts RefSeq Transcripts (Human)
AccessionTypeStatusMANE Select
NM_006218.4mRNAREVIEWEDYes (Canonical)
XM_006713658mRNAPREDICTEDNo
XM_054346842mRNAPREDICTEDNo
XM_054346843mRNAPREDICTEDNo
XM_054346844mRNAPREDICTEDNo
XM_054346845mRNAPREDICTEDNo
XM_054346846mRNAPREDICTEDNo
XM_054346847mRNAPREDICTEDNo
XM_054346848mRNAPREDICTEDNo
CCDS
IDDescription
CCDS43171.1Consensus coding sequence
Canonical Transcript Exons (ENST00000263967) - Total: 21
Exon IDStartEndLength (bp)
ENSE00001493081179,148,357179,148,603247
ENSE00001139995179,198,750179,199,177428
ENSE00000997375179,199,690179,199,899210
ENSE00001077693179,201,290179,201,540251
ENSE00001077692179,203,544179,203,789246
ENSE00001077694179,204,503179,204,58886
ENSE00001077691179,209,595179,209,700106
ENSE00001128470179,210,186179,210,338153
ENSE00001128465179,210,431179,210,565135
ENSE00001077674179,218,210179,218,334125
ENSE00000826291179,219,196179,219,27782
ENSE00000826292179,219,571179,219,735165
ENSE00003485038179,219,949179,220,052104
ENSE00003568097179,220,986179,221,157172
ENSE00003489671179,224,081179,224,187107
ENSE00003485539179,224,700179,224,821122
ENSE00000826297179,225,962179,226,04079
ENSE00000826298179,229,272179,229,442171
ENSE00000826299179,230,004179,230,121118
ENSE00000826300179,230,225179,230,376152
ENSE00001139987179,234,094179,240,0936,000

Section 3: Protein Identifiers UniProt Accessions (Total: 6)

AccessionStatusDescription
P42336Reviewed (Swiss-Prot)Canonical entry
A0A2R8Y2F6UnreviewedIsoform
A0A6Q8PGN9UnreviewedIsoform
A0A6Q8PGV1UnreviewedIsoform
C9J951UnreviewedIsoform
C9JAM9UnreviewedIsoform
Canonical Protein (P42336)
PropertyValue
Length1,068 amino acids
Mass124,284 Da
Full NamePhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
Alternative NamesPI3-kinase p110-alpha, PI3Kalpha, Serine/threonine protein kinase PIK3CA
RefSeq Proteins (Human)
AccessionTypeStatus
NP_006209.2proteinREVIEWED
XP_006713721predicted_proteinPREDICTED
XP_054202817-823predicted_proteinPREDICTED
Protein Domains and Families (InterPro) - Total: 14
InterPro IDNameType
IPR000341PI3K_Ras-bd_domDomain
IPR000403PI3/4_kinase_cat_domDomain
IPR001263PI3K_accessory_domDomain
IPR002420PI3K-type_C2_domDomain
IPR003113PI3K_ABDDomain
IPR037704PI3-kinase_alpha_catDomain
IPR015433PI3/4_kinaseFamily
IPR018936PI3/4_kinase_CSConserved_site
IPR011009Kinase-like_dom_sfHomologous_superfamily
IPR016024ARM-type_foldHomologous_superfamily
IPR029071Ubiquitin-like_domsfHomologous_superfamily
IPR035892C2_domain_sfHomologous_superfamily
IPR036940PI3/4_kinase_cat_sfHomologous_superfamily
IPR042236PI3K_accessory_sfHomologous_superfamily

Section 4: Structure Identifiers Experimental Structures (PDB) - Total: 125+ X-ray Crystallography Structures (Top 50 by resolution)

PDB IDResolution (Å)Title
9ASF1.77HLA-A*03:01 with WT PIK3CA peptide
9CML1.75p110alpha-RBD with molecular glue D223
7L1C1.96HLA-A*03:01 with mutant PIK3CA peptide
8EXL1.99PI3K-alpha with taselisib
9CWY1.98HLA-A*03:01 with WT PIK3CA peptide
9CWZ2.05HLA-A*03:02 with mutant PIK3CA peptide
7RRG2.12TCR bound to HLA-A*03:01 with PIK3CA peptide
7JIU2.12PI3Kdelta with compound 2F
6PYS2.19PI3Kalpha with compound 2-10
7PG52.20PI3Kalpha crystal structure
9B4U2.21p110alpha-RBD with breaker compound
4JPS2.20PI3K alpha with inhibitors
5DXT2.25p110alpha with GDC-0326
8SBC2.30PI3K alpha with brain penetrant inhibitors
6VO72.31PI3K-alpha RBD
4WAF2.39PI3K alpha with tetrahydropyrazolo compound
7K6M2.41PI3Kalpha with PF-06843195
8BFU2.41Apo p110alpha
7TZ72.41PI3K alpha with inhibitor
8EXO2.46PI3K-alpha with compound 19
8EXV2.48PI3K-alpha with compound 32
7PG62.50PI3Kalpha with NVP-BYL719
5UK82.50PI3K-alpha mutant mimic
5FI42.50PI3K with imidazopyridine inhibitor
6GVF2.50PI3K alpha with benzooxazole compound
8TSA2.51PI3K p85alpha/p110alpha H1047R with compound 2
5XGI2.56PI3K with inhibitor
4L1B2.59p110alpha with niSH2 of p85alpha
8V8V2.61PI3Ka H1047R with compound 7
4ZOP2.62PI3K alpha with selective inhibitor
8GUD2.62PI3Kalpha E545K with BYL-719
4TUU2.64Isolated p110a subunit
8OW22.57p110alpha with activator 1938
8TWY2.67p110 alpha with compound 9
8EXU2.68PI3K-alpha with compound 30
8TSD2.70PI3K p85alpha/p110alpha with RLY-2608
8TS72.71PI3K p85alpha/p110alpha
8TS82.72p85alpha/p110alpha H1047R
6GVH2.74PI3K alpha with benzooxazole compound
7K6N2.77PI3Kalpha with 11-1575
9B4T2.75MRAS-p110alpha complex
3HHM2.80p110alpha H1047R with wortmannin
4L2Y2.80p110alpha with compound 9d
5UKJ2.80PI3K-alpha mutant with sulfonamide
9C152.81KRAS-p110alpha with molecular glue
8AM02.82T1061E PI3Kalpha with GDC-0077/Inavolisib
9E8M2.83VVD-442 bound to PI3Ka RBD
8TS92.83PI3K H1047R with compound 1
4TV32.85Isolated p110a with inhibitor
3ZIM2.85PI3Kalpha with covalent inhibitor
Cryo-EM Structures
PDB IDResolution (Å)Title
8DCP2.41PI3K alpha with nanobody 3-126
8GUD2.62PI3Kalpha E545K with BYL-719
8GUB2.73PI3Kalpha H1047R with BYL-719
8GUA2.77PI3Kalpha E542K with BYL-719
7MYN2.79p110alpha/p85alpha complex
8DCX2.80PI3K alpha with nanobody 3-159
7MYO2.92p110alpha/p85alpha with BYL-719
9LWS2.94PI3Kalpha H1047R with UCL-TRO-1938
8ILR3.05PI3Kalpha with compound 16
8ILS3.10PI3Kalpha with compound 17
8DD43.10PI3K alpha with nanobody 3-142
8TU63.12PI3Kalpha cryo-EM
9LWQ3.17PI3Kalpha with UCL-TRO-1938
8ILV3.19PI3Kalpha with compound 18
9LWR3.30PI3Kalpha H1047R with UCL-TRO-1938
8DD83.40PI3K alpha with nanobody, crosslinked
NMR Structure
PDB IDMethodTitle
2ENQSOLUTION NMRC2 domain of PI3-kinase p110 alpha
Predicted Structure (AlphaFold)
Model IDGlobal pLDDTSequence LengthHigh Confidence (%)
P4233692.508,72283%

Section 5: Cross-Species Orthologs Model Organism Orthologs

OrganismGene IDSymbolBiotype
Mouse (Mus musculus)ENSMUSG00000027665Pik3caprotein_coding
Rat (Rattus norvegicus)ENSRNOG00000056371Pik3caprotein_coding
Zebrafish (Danio rerio)ENSDARG00000075456pik3caprotein_coding
Fruit fly (Drosophila melanogaster)FBGN0015278Pi3K68Dprotein_coding
Worm (C. elegans)WBGENE00009552--
Yeast (S. cerevisiae)--No ortholog
Human Paralogs (PI3K Family) - Total: 9
Gene IDSymbolDescription
ENSG00000051382PIK3CBPI3K catalytic beta
ENSG00000171608PIK3CDPI3K catalytic delta
ENSG00000105851PIK3CGPI3K catalytic gamma
ENSG00000078142PIK3C3PI3K class III
ENSG00000011405PIK3C2API3K class 2 alpha
ENSG00000133056PIK3C2BPI3K class 2 beta
ENSG00000139144PIK3C2GPI3K class 2 gamma
ENSG00000143393PI4KBPI4K beta
ENSG00000241973PI4KAPI4K alpha

Section 6: Clinical Variants & AI Predictions ClinVar Summary

ClassificationCount
Total Variants1,566+
Pathogenic52
Likely Pathogenic39
Pathogenic/Likely Pathogenic10
Uncertain Significance (VUS)~300
Likely Benign~700
Benign~100
Top 50 Pathogenic/Likely Pathogenic Variants
ClinVar IDHGVSProtein ChangeClassificationCondition
13652c.3140A>Gp.His1047ArgPathogenic (Expert)Multiple overgrowth syndromes
31944c.1624G>Ap.Glu542LysPathogenic (Expert)Cancer/overgrowth syndromes
376476c.2176G>Ap.Glu726LysPathogenic (Expert)MCAP syndrome
39703c.2740G>Ap.Gly914ArgPathogenic (Expert)Overgrowth syndromes
13653c.3140A>Tp.His1047LeuPathogenicMCAP/cancer
217293c.1635G>Tp.Glu545AspPathogenicCancer syndromes
13657c.1636C>Ap.Gln546LysPathogenicCancer syndromes
156446c.353G>Ap.Gly118AspPathogenicMCAP syndrome
376049c.263G>Ap.Arg88GlnPathogenicOvergrowth syndromes
376050c.1035T>Ap.Asn345LysPathogenicCancer syndromes
376247c.3145G>Ap.Gly1049SerPathogenicMCAP syndrome
376470c.1357G>Ap.Glu453LysPathogenicOvergrowth syndromes
376478c.241G>Ap.Glu81LysPathogenicCancer/overgrowth
376498c.1030G>Ap.Val344MetPathogenicCancer syndromes
217292c.3129G>Tp.Met1043IlePathogenicCLOVES syndrome
31945c.1258T>Cp.Cys420ArgPathogenicMCAP syndrome
39704c.1133G>Ap.Cys378TyrPathogenicMCAP syndrome
39705c.3139C>Tp.His1047TyrPathogenicCancer syndromes
419128c.278G>Ap.Arg93GlnPathogenicMCAP syndrome
419222c.1093G>Ap.Glu365LysPathogenicMCAP syndrome
419390c.3131A>Gp.Asn1044SerPathogenicOvergrowth syndromes
521363c.1049A>Gp.Asp350GlyPathogenicCancer syndromes
917489c.1132T>Cp.Cys378ArgPathogenicMCAP syndrome
1172582c.344G>Cp.Arg115ProPathogenic/LPMCAP syndrome
1172583c.3104C>Tp.Ala1035ValPathogenicOvergrowth syndromes
1057635c.2908G>Ap.Glu970LysPathogenic/LPMCAP syndrome
1098323c.2816A>Gp.Asp939GlyPathogenic/LPCancer syndromes
1198826c.277G>Ap.Arg93TrpPathogenic/LPOvergrowth syndromes
1209066c.3012G>Ap.Met1004IlePathogenic/LPCancer syndromes
13659c.1634A>Cp.Glu545AlaPathogenicCancer syndromes
13656c.1634A>Gp.Glu545GlyPathogenicCancer syndromes
156447c.403G>Ap.Glu135LysPathogenicMCAP syndrome
156448c.652G>Ap.Glu218LysPathogenicOvergrowth syndromes
156449c.1066G>Ap.Val356IlePathogenicCancer syndromes
376246c.3062A>Gp.Tyr1021CysPathogenicCancer syndromes
2580765c.1034A>Gp.Asn345SerPathogenicCancer syndromes
2662642c.1798G>Ap.Glu600LysPathogenicOvergrowth syndromes
45464c.1252G>Ap.Glu418LysPathogenicMCAP syndrome
45466c.1637A>Gp.Gln546ArgPathogenicCancer syndromes
3777340c.3193C>Tp.His1065TyrPathogenicOvergrowth syndromes
3778701c.3103G>Ap.Ala1035ThrPathogenicCancer syndromes
1333708c.3127A>Cp.Met1043LeuLikely pathogenicOvergrowth
13654c.1636C>Gp.Gln546GluLikely pathogenicCancer
376475c.1625A>Gp.Glu542GlyLikely pathogenicCancer
376492c.113G>Ap.Arg38HisLikely pathogenicMCAP syndrome
421698c.2758A>Gp.Asn920AspLikely pathogenicOvergrowth
1511013c.3145G>Tp.Gly1049CysLikely pathogenicOvergrowth
2505160c.2702G>Tp.Cys901PheLikely pathogenicCancer
995382c.325GAA[1]p.Glu110delLikely pathogenic (Expert)MCAP
372875c.1259_1261dupp.Cys420_Pro421insArgLikely pathogenicMCAP
SpliceAI Predictions - Total: 3,028 Top 50 Predicted Splice-Altering Variants (Score ≥ 0.5)
VariantEffectDelta Score
3:179148600:GAGC:Gdonor_gain1.00
3:179148601:AGC:Adonor_gain1.00
3:179148602:GC:Gdonor_gain1.00
3:179148602:GCG:Gdonor_gain1.00
3:179148604:G:GGdonor_gain1.00
3:179148590:G:GTdonor_gain0.99
3:179148599:CGAGC:Cdonor_gain0.99
3:179148600:GAGCG:Gdonor_gain0.99
3:179148603:CG:Cdonor_loss0.99
3:179148604:G:GCdonor_loss0.99
3:179148605:T:Gdonor_loss0.99
3:179148607:A:ATdonor_loss0.99
3:179148608:G:GGdonor_gain0.99
3:179148608:G:Cdonor_loss0.98
3:179148607:A:AGdonor_gain0.98
3:179148628:T:TAdonor_gain0.96
3:179148629:A:AAdonor_gain0.96
3:179148630:GCGG:Gdonor_gain0.95
3:179148632:G:Adonor_gain0.90
3:179148901:G:GTdonor_gain0.86
3:179148607:AGT:Adonor_gain0.85
3:179148609:T:Adonor_gain0.83
3:179148605:T:TCdonor_gain0.81
3:179148803:C:Tdonor_gain0.81
3:179148603:CGTGA:Cdonor_gain0.80
3:179148604:GT:Gdonor_gain0.80
3:179148605:TGAGT:Tdonor_gain0.80
3:179148608:GT:Gdonor_gain0.80
3:179148601:AGCGT:Adonor_gain0.79
3:179148602:GCGTG:Gdonor_gain0.79
3:179148606:G:GGdonor_gain0.78
3:179148606:GA:Gdonor_gain0.78
3:179148124:GGG:Gdonor_gain0.75
3:179148125:GGG:Gdonor_gain0.75
3:179148610:AG:Adonor_gain0.75
3:179149106:GGTT:Gdonor_gain0.70
3:179149132:G:GTdonor_gain0.69
3:179149136:G:GTdonor_gain0.68
3:179149189:T:TAdonor_gain0.65
3:179148636:G:Adonor_gain0.65
3:179148573:T:Adonor_gain0.64
3:179149010:G:Tdonor_gain0.62
3:179148625:C:CAdonor_gain0.61
3:179148638:G:GTdonor_gain0.58
3:179149107:GTT:Gdonor_gain0.55
3:179149108:TTT:Tdonor_gain0.55
3:179149123:AGG:Adonor_gain0.53
3:179149128:TATGG:Tdonor_gain0.52
3:179149129:ATGGA:Adonor_gain0.52
3:179149190:T:TAdonor_gain0.52
AlphaMissense Predictions - Total: 7,111 Top 50 Predicted Pathogenic Missense Variants (Score ≥ 0.9)
VariantAA ChangeScoreClassification
3:179198856:T:AW11R0.998likely_pathogenic
3:179198856:T:CW11R0.998likely_pathogenic
3:179198858:G:CW11C0.995likely_pathogenic
3:179198858:G:TW11C0.995likely_pathogenic
3:179198872:T:CM16T0.993likely_pathogenic
3:179198850:G:AE9K0.988likely_pathogenic
3:179198854:T:CL10P0.987likely_pathogenic
3:179198859:G:CG12R0.987likely_pathogenic
3:179198873:G:AM16I0.987likely_pathogenic
3:179198873:G:CM16I0.987likely_pathogenic
3:179198873:G:TM16I0.987likely_pathogenic
3:179198872:T:AM16K0.984likely_pathogenic
3:179198857:G:CW11S0.984likely_pathogenic
3:179198872:T:GM16R0.985likely_pathogenic
3:179198848:G:AG8D0.977likely_pathogenic
3:179198851:A:TE9V0.974likely_pathogenic
3:179198854:T:AL10Q0.974likely_pathogenic
3:179198848:G:TG8V0.972likely_pathogenic
3:179198847:G:TG8C0.962likely_pathogenic
3:179198857:G:TW11L0.961likely_pathogenic
3:179198851:A:CE9A0.958likely_pathogenic
3:179198854:T:GL10R0.953likely_pathogenic
3:179198851:A:GE9G0.951likely_pathogenic
3:179198856:T:GW11G0.947likely_pathogenic
3:179198860:G:TG12V0.945likely_pathogenic
3:179198850:G:CE9Q0.942likely_pathogenic
3:179198860:G:AG12D0.941likely_pathogenic
3:179198845:C:TS7L0.926likely_pathogenic
3:179198839:C:AP5Q0.926likely_pathogenic
3:179198875:C:AP17H0.922likely_pathogenic
3:179198875:C:GP17R0.918likely_pathogenic
3:179198839:C:GP5R0.914likely_pathogenic
3:179198859:G:TG12C0.912likely_pathogenic
3:179198852:A:CE9D0.904likely_pathogenic
3:179198852:A:TE9D0.904likely_pathogenic
3:179198871:A:GM16V0.892likely_pathogenic
3:179198838:C:AP5T0.890likely_pathogenic
3:179198839:C:TP5L0.890likely_pathogenic
3:179198847:G:AG8S0.882likely_pathogenic
3:179198838:C:TP5S0.880likely_pathogenic
3:179198848:G:CG8A0.876likely_pathogenic
3:179198875:C:TP17L0.873likely_pathogenic
3:179198874:C:AP17T0.868likely_pathogenic
3:179198844:T:CS7P0.868likely_pathogenic
3:179198842:C:TS6L0.858likely_pathogenic
3:179198841:T:CS6P0.834likely_pathogenic
3:179198874:C:TP17S0.830likely_pathogenic
3:179198859:G:AG12S0.806likely_pathogenic
3:179198869:T:CL15S0.770likely_pathogenic
3:179198865:C:GH14D0.757likely_pathogenic

Section 7: Biological Pathways & Gene Ontology Pathway Membership (Reactome) - Total: 60

Pathway IDPathway NameDisease Pathway
R-HSA-109704PI3K CascadeNo
R-HSA-1257604PIP3 activates AKT signalingNo
R-HSA-112399IRS-mediated signallingNo
R-HSA-114604GPVI-mediated activation cascadeNo
R-HSA-1433557Signaling by SCF-KITNo
R-HSA-1660499Synthesis of PIPs at the plasma membraneNo
R-HSA-180292GAB1 signalosomeNo
R-HSA-186763Downstream signal transductionNo
R-HSA-1963642PI3K events in ERBB2 signalingNo
R-HSA-198203PI3K/AKT activationNo
R-HSA-201556Signaling by ALKNo
R-HSA-202424Downstream TCR signalingNo
R-HSA-2029485Role of phospholipids in phagocytosisNo
R-HSA-210993Tie2 SignalingNo
R-HSA-2424491DAP12 signalingNo
R-HSA-2730905Role of LAT2/NTAL/LAB on calcium mobilizationNo
R-HSA-373753Nephrin family interactionsNo
R-HSA-389357CD28 dependent PI3K/Akt signalingNo
R-HSA-416476G alpha (q) signalling eventsNo
R-HSA-4420097VEGFA-VEGFR2 PathwayNo
R-HSA-512988IL-3, IL-5 and GM-CSF signalingNo
R-HSA-5654689PI-3K cascade:FGFR1No
R-HSA-5654695PI-3K cascade:FGFR2No
R-HSA-5654710PI-3K cascade:FGFR3No
R-HSA-5654720PI-3K cascade:FGFR4No
R-HSA-5673001RAF/MAP kinase cascadeNo
R-HSA-6811558PI5P, PP2A and IER3 Regulate PI3K/AKT SignalingNo
R-HSA-8851907MET activates PI3K/AKT signalingNo
R-HSA-8853659RET signalingNo
R-HSA-9009391Extra-nuclear estrogen signalingNo
R-HSA-9013149RAC1 GTPase cycleNo
R-HSA-9013404RAC2 GTPase cycleNo
R-HSA-9027276Erythropoietin activates PI3KNo
R-HSA-9028335Activated NTRK2 signals through PI3KNo
R-HSA-912526Interleukin receptor SHC signalingNo
R-HSA-912631Regulation of signaling by CBLNo
R-HSA-9603381Activated NTRK3 signals through PI3KNo
R-HSA-9607240FLT3 SignalingNo
R-HSA-9680350Signaling by CSF1 (M-CSF) in myeloid cellsNo
R-HSA-9842663Signaling by LTKNo
R-HSA-9856530PIEZO1/PECAM1/CDH5/KDR signaling in endotheliumNo
R-HSA-9927354Co-stimulation by ICOSNo
R-HSA-2219530Constitutive Signaling by Aberrant PI3K in CancerYes
R-HSA-1236382Constitutive Signaling by Ligand-Responsive EGFR Cancer VariantsYes
R-HSA-5637810Constitutive Signaling by EGFRvIIIYes
R-HSA-1839117Signaling by cytosolic FGFR1 fusion mutantsYes
R-HSA-5655253Signaling by FGFR2 in diseaseYes
R-HSA-5655291Signaling by FGFR4 in diseaseYes
R-HSA-5655302Signaling by FGFR1 in diseaseYes
R-HSA-5655332Signaling by FGFR3 in diseaseYes
R-HSA-9664565Signaling by ERBB2 KD MutantsYes
R-HSA-9665348Signaling by ERBB2 ECD mutantsYes
R-HSA-9670439Signaling by phosphorylated KIT mutantsYes
R-HSA-9673767Signaling by PDGFRA transmembrane/kinase mutantsYes
R-HSA-9673770Signaling by PDGFRA extracellular domain mutantsYes
R-HSA-9703465Signaling by FLT3 fusion proteinsYes
R-HSA-9703648Signaling by FLT3 ITD and TKD mutantsYes
R-HSA-9725370Signaling by ALK fusions and point mutantsYes
R-HSA-9842640Signaling by LTK in cancerYes
Gene Ontology Annotations - Total: 66 Molecular Function (13 terms)
GO IDTerm
GO:00163031-phosphatidylinositol-3-kinase activity
GO:00469341-phosphatidylinositol-4,5-bisphosphate 3-kinase activity
GO:00350051-phosphatidylinositol-4-phosphate 3-kinase activity
GO:0004674protein serine/threonine kinase activity
GO:0106310protein serine kinase activity
GO:0005524ATP binding
GO:0030295protein kinase activator activity
GO:0043560insulin receptor substrate binding
Biological Process (48 terms - TOP 20)
GO IDTerm
GO:0048015phosphatidylinositol-mediated signaling
GO:0043491phosphatidylinositol 3-kinase/protein kinase B signal transduction
GO:0036092phosphatidylinositol-3-phosphate biosynthetic process
GO:0046854phosphatidylinositol phosphate biosynthetic process
GO:0007173epidermal growth factor receptor signaling pathway
GO:0008286insulin receptor signaling pathway
GO:0048009insulin-like growth factor receptor signaling pathway
GO:0038084vascular endothelial growth factor signaling pathway
GO:0050852T cell receptor signaling pathway
GO:0051897positive regulation of PI3K/PKB signal transduction
GO:0032008positive regulation of TOR signaling
GO:0038203TORC2 signaling
GO:0001525angiogenesis
GO:0001944vasculature development
GO:0016477cell migration
GO:0043542endothelial cell migration
GO:0030168platelet activation
GO:0006909phagocytosis
GO:0032869cellular response to insulin stimulus
GO:0006006glucose metabolic process
Cellular Component (10 terms)
GO IDTerm
GO:0005942phosphatidylinositol 3-kinase complex
GO:0005943phosphatidylinositol 3-kinase complex, class IA
GO:0005944phosphatidylinositol 3-kinase complex, class IB
GO:0005737cytoplasm
GO:0005829cytosol
GO:0005886plasma membrane
GO:0030027lamellipodium
GO:0048471perinuclear region of cytoplasm
GO:0014704intercalated disc

Section 8: Protein Interactions & Molecular Networks Protein-Protein Interactions (STRING) - Total: 4,602 Top 50 Highest-Confidence Interactors

UniProt IDGeneConfidence Score
P27986PIK3R1 (p85alpha)998
P42336PIK3CA (self)998
O00459PIK3R2 (p85beta)997
Q92569PIK3R3 (p55gamma)995
Q8WYR1PIK3R5992
P42338PIK3CB984
O00329PIK3CD983
P00533EGFR977
P48736PIK3CG973
P01116KRAS952
P35568IRS1952
P31749AKT1951
P60484PTEN949
P15056BRAF931
P04626ERBB2 (HER2)927
P01111NRAS921
P04637TP53920
Q14155BEX4912
O14497ARID1A911
P22607FGFR3902
P35222CTNNB1 (beta-catenin)890
P16234PDGFRA867
P21860ERBB3856
P12931SRC847
Q969H0FBXW7845
P31751AKT2841
Q9Y243AKT3839
P03372ESR1817
Q15831STK11 (LKB1)817
Q02750MAP2K1815
P51587BRCA2812
P10721KIT810
P28482MAPK1810
P01112HRAS801
Q9UM73ALK801
P42771CDKN2A (p16)791
P21359NF1790
P40692MLH1788
P07949RET781
P11362FGFR1778
P08069IGF1R776
P30153PPP2R1A773
P09619PDGFRB764
Q13485SMAD4763
Q6R327RAPGEF5757
O60674JAK2755
P00519ABL1755
P35968VEGFR2 (KDR)754
O15530PDPK1 (PDK1)744
P50148GNAQ741
BioGRID Interactions - Total: 303+ Key experimental interactions detected by affinity capture-MS, two-hybrid, and biochemical assays. IntAct Interactions - Total: 250+ Top 20 High-Confidence Direct Interactions (Score ≥ 0.9)
PartnerInteraction TypeScore
PIK3R1Direct interaction0.960
PIK3R1Physical association0.960
PIK3R2Physical association0.900
PIK3R3Physical association0.900
GRB2Physical association0.800
Protein Similarity Structural/Embedding Similarity (ESM2) - Total: 135 Top 20 Most Similar Proteins
UniProt IDTop SimilarityAvg Similarity
A0A0G2K3441.00000.9872
D3ZGS30.99980.9862
P42337 (PIK3CB)1.00000.9872
O887631.00000.9875
P328711.00000.9869
O359040.99960.9874
Q6AZN60.99960.9870
P42338 (PIK3CD)0.99980.9867
O00329 (PIK3CG)0.99960.9865
P48736 (PIK3CG)0.99970.9848
Sequence Homology (DIAMOND) - Total: 30
UniProt IDTop Identity (%)Bitscore
P42336 (self)99.802182
A0A0G2K34499.702176
P4233799.702176
P3287199.802183
Q5RAY198.603256
O0044398.603260
Q8BTI998.402107
Q9Z1L098.402109
P4233895.902079
P4873694.902119
O0269794.902118
O0032994.501987
O3590494.501983
Q9JHG794.102105
Q6119490.103008
O7017387.402663
O7016787.402658
Q0WPX985.701576
O7574772.302189

Section 9: Transcription Factor Regulatory Data PIK3CA is NOT a transcription factor. However, its expression is regulated by several TFs: Upstream Regulators (TFs that regulate PIK3CA)

TF GeneRegulationConfidence
TP53RepressionHigh
YBX1ActivationHigh
FOXO3UnknownHigh
SOX9Activation-
HIF1AUnknown-
NFKBUnknownLow

Section 10: Drug & Pharmacology Data ChEMBL Target Information

PropertyValue
Target IDCHEMBL4005
Target TypeSINGLE PROTEIN
MechanismPI3-kinase p110-alpha subunit inhibitor
Action TypeINHIBITOR
Total Molecules7,630
Total Assays1,726
Total Activities9,474
Approved Drugs (Phase 4) - Total: 13
ChEMBL IDDrug NameTypeIndication
CHEMBL2396661ALPELISIB (Piqray)Small moleculePIK3CA-mutated breast cancer
CHEMBL4650215INAVOLISIB (Itovebi)Small moleculePIK3CA-mutated breast cancer
CHEMBL2216870IDELALISIBSmall moleculeCLL, FL, SLL
CHEMBL3039502DUVELISIBSmall moleculeCLL/SLL, FL
CHEMBL3218576COPANLISIBSmall moleculeFL
CHEMBL3545068COPANLISIB HClSmall moleculeFL
CHEMBL3643413LENIOLISIBSmall moleculeAPDS
CHEMBL535SUNITINIBSmall moleculeRCC, GIST
CHEMBL5416410DASATINIBSmall moleculeCML, ALL
CHEMBL601719CRIZOTINIBSmall moleculeALK+ NSCLC
CHEMBL608533MIDOSTAURINSmall moleculeAML
CHEMBL1287853FEDRATINIBSmall moleculeMyelofibrosis
CHEMBL343448ROMIDEPSINProteinCTCL
Phase 3 Clinical Candidates - Total: 7
ChEMBL IDDrug NameType
CHEMBL1879463DACTOLISIBSmall molecule
CHEMBL2017974BUPARLISIBSmall molecule
CHEMBL2387080TASELISIBSmall molecule
CHEMBL592445GEDATOLISIBSmall molecule
CHEMBL603469LESTAURTINIBSmall molecule
CHEMBL165RESVERATROLSmall molecule
CHEMBL297453EPIGALLOCATECHIN GALLATESmall molecule
BindingDB Ligands - Total: 12,080+ High-affinity binders with IC50 values in sub-nanomolar to nanomolar range. PharmGKB Information
PropertyValue
PharmGKB IDPA33308
VIP GeneYes
CPIC GuidelineNo
Chromosomechr3

Section 11: Expression Profiles Tissue Expression (Bgee)

PropertyValue
Expression BreadthUbiquitous
Total Present Calls284
Max Expression Score94.28
Top 30 Tissues by Expression Score
TissueExpression ScoreRank
Calcaneal tendon94.282,670
Adrenal tissue94.022,790
Tendon92.683,410
Cortical plate89.874,720
Primordial germ cell (gonad)88.345,440
Male germ line stem cell88.245,480
Tendon of biceps brachii88.115,540
Ventricular zone88.045,580
Secondary oocyte87.315,920
Ganglionic eminence87.305,920
Cartilage tissue87.165,990
Heart right ventricle86.416,330
Skin of hip86.306,390
Bone marrow86.176,450
Biceps brachii86.166,450
Colonic epithelium86.156,460
Endometrial stromal cell85.946,550
Popliteal artery85.786,630
Tibial artery85.776,630
Subcutaneous adipose tissue85.756,640
Abdominal adipose tissue85.716,660
Connective tissue85.686,680
Adipose tissue85.676,680
Bone marrow cell85.646,690
Omental fat pad85.586,720
Peritoneum85.526,750
Artery85.486,770
Biceps brachii skeletal muscle85.476,780
Postcentral gyrus85.406,810
Medial globus pallidus85.186,910
Cell Type Expression (Top 30)
Cell TypeExpression Score
Primordial germ cell88.34
Male germ line stem cell88.24
Secondary oocyte87.31
Endometrial stromal cell85.94
Bone marrow cell85.64
Endothelial cell84.48
Monocyte83.90
Leukocyte83.82
Mononuclear cell83.74
Buccal mucosa cell82.45
Oocyte79.90
Granulocyte79.89

Section 12: Disease Associations Mendelian/Monogenic Diseases (GenCC) - Total: 7

DiseaseOMIM/MONDOClassificationInheritanceEvidence
Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP)OMIM:602501StrongADMultiple submitters
Cowden syndrome 5OMIM:615108LimitedADLabcorp
Cowden diseaseORPHA:201SupportiveADOrphanet
Vascular malformationMONDO:0024291StrongADPanelApp
Familial ovarian cancerMONDO:0016248No known relationshipUnknownClinGen
Orphanet Disease Associations - Total: 15
Orphanet IDDisease NameTypeGene Count
60040MCAP syndromeMalformation syndrome1
140944CLOVES syndromeMalformation syndrome1
168984CLAPO syndromeMalformation syndrome1
201Cowden syndromeClinical subtype9
276280Hemihyperplasia-multiple lipomatosis syndromeMalformation syndrome1
314662Segmental progressive overgrowth with FAHDisease1
99802HemimegalencephalyMalformation syndrome3
714737Diffuse capillary malformation with overgrowthMorphological anomaly2
90308Capillary-lymphatic-venous malformationDisease2
295239Macrodactyly of fingers, unilateralClinical subtype1
295243Macrodactyly of toes, unilateralClinical subtype1
2495MeningiomaDisease12
210159Adult hepatocellular carcinomaDisease9
144Lynch syndromeDisease9
221061Familial cerebral cavernous malformationMalformation syndrome4
HPO Phenotype Associations - Total: 383 Top 50 Phenotype Terms
HPO IDPhenotype
HP:0000006Autosomal dominant inheritance
HP:0000256Macrocephaly
HP:0001249Intellectual disability
HP:0001250Seizure
HP:0001263Global developmental delay
HP:0001252Hypotonia
HP:0000238Hydrocephalus
HP:0000717Autism
HP:0001028Hemangioma
HP:0001052Nevus flammeus
HP:0001004Lymphedema
HP:0000324Facial asymmetry
HP:0000965Cutis marmorata
HP:0000505Visual impairment
HP:0000316Hypertelorism
HP:0000158Macroglossia
HP:0001156Brachydactyly
HP:0001159Syndactyly
HP:0001161Hand polydactyly
HP:0000365Hearing impairment
HP:0000518Cataract
HP:0000508Ptosis
HP:0000098Tall stature
HP:0000767Pectus excavatum
HP:0000969Edema
HP:0001012Multiple lipomas
HP:0001031Subcutaneous lipoma
HP:0000771Gynecomastia
HP:0001048Cavernous hemangioma
HP:0001054Numerous nevi
HP:0001067Neurofibroma
HP:0000347Micrognathia
HP:0000337Broad forehead
HP:0000348High forehead
HP:0000293Full cheeks
HP:0000218High palate
HP:0000154Wide mouth
HP:0000107Renal cyst
HP:0000138Ovarian cyst
HP:0000820Thyroid abnormality
HP:0000853Goiter
HP:0000854Thyroid adenoma
HP:0000716Depression
HP:0000739Anxiety
HP:0000712Emotional lability
HP:0000737Irritability
HP:0001251Ataxia
HP:0001260Dysarthria
HP:0001269Hemiparesis
HP:0001276Hypertonia
GWAS Associations - Total: 8
Study IDTraitP-value
GCST90002392Mean corpuscular volume4.0e-23
GCST90002390Mean corpuscular hemoglobin2.0e-19
GCST90002403Red blood cell count2.0e-16
GCST90002397Mean spheric corpuscular volume1.0e-11
GCST90002396Mean reticulocyte volume1.0e-10
GCST90002406Reticulocyte fraction of red cells5.0e-09
GCST010002Refractive error2.0e-09
GCST005993Mean corpuscular hemoglobin3.0e-08

Summary Statistics

CategoryCount
Gene identifiers5 databases
Transcripts (Ensembl)15
RefSeq transcripts (human)9+
Exons (canonical)21
UniProt entries6
InterPro domains14
PDB structures125+
Model organism orthologs5
Human paralogs9
ClinVar variants1,566+
Pathogenic variants52
SpliceAI predictions3,028
AlphaMissense predictions7,111
Reactome pathways60
GO annotations66
STRING interactions4,602
IntAct interactions250+
ChEMBL molecules7,630
Approved drugs13
Orphanet diseases15
HPO phenotypes383
GWAS associations8

Reference compiled from: HGNC, Ensembl, NCBI, UniProt, PDB, AlphaFold, ClinVar, SpliceAI, AlphaMissense, Reactome, Gene Ontology, STRING, IntAct, BioGRID, ChEMBL, BindingDB, PharmGKB, Bgee, GenCC, Orphanet, HPO, GWAS Catalog I’ve compiled a comprehensive cross-database identifier and functional mapping reference for human PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha). Key highlights:

  • PIK3CA is one of the most frequently mutated oncogenes in human cancer
  • The canonical hotspot mutations (H1047R, E542K, E545K) are among the most common cancer-driving mutations
  • 125+ experimental structures in PDB, making it one of the most structurally characterized kinases
  • 13 FDA-approved drugs target this protein, including the PI3Kα-selective inhibitors alpelisib (Piqray) and inavolisib (Itovebi) for PIK3CA-mutated breast cancer
  • Ubiquitous tissue expression with highest levels in tendon, adrenal tissue, and developing brain
  • Associated with overgrowth syndromes (MCAP, CLOVES, CLAPO) and Cowden syndrome
  • 7,111 AlphaMissense predictions and 3,028 SpliceAI predictions available for variant interpretation